GARRETT SCOTT T

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GARRETT SCOTT T's trades of HCW Biologics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-22
B Purchase
83,995 -1.0%
253.27
US$2,907,951 		83,995 -1.0% 253.27 US$2,907,951
2025-05-20 2025-05-16
B Purchase
36,314 +1.5%
438.55
US$3,465,777 		36,314 +1.5% 438.55 US$3,465,777
2025-05-09 2025-05-08
B Purchase
52,757 -3.3%
241.29
US$876,736 		52,757 -3.3% 241.29 US$876,736
2024-03-15 2024-03-14
US Hologic Inc (HOLX)
S Sale
16,441 -25.3%
75.50
US$1,241,296 		16,441 -25.3% 75.50 US$1,241,296
2024-03-14 2024-03-14
US Hologic Inc (HOLX)
PrS Proposed sale
16,441
75.50
US$1,241,296 		16,441 75.50 US$1,241,296
2023-12-13 2023-12-11
US Hologic Inc (HOLX)
S Sale
10,000 -17.5%
68.71
US$687,116 		10,000 -17.5% 68.71 US$687,116
2023-12-11 2023-12-11
US Hologic Inc (HOLX)
PrS Proposed sale
10,000
68.71
US$687,116 		10,000 68.71 US$687,116
2023-06-20 2023-06-15
US Hologic Inc (HOLX)
S Sale
10,000 -14.9%
79.72
US$797,240 		10,000 -14.9% 79.72 US$797,240
2023-06-15 2023-06-15
US Hologic Inc (HOLX)
PrS Proposed sale
10,000
79.72
US$797,239 		10,000 79.72 US$797,239
2021-07-23 2021-07-22
B Purchase
125,000 +inf%
8.00
US$1,000,000 		125,000 +inf% 8.00 US$1,000,000